Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients.

Ann Transplant · 2018 · PMC6248066 · PMID 29311539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In this study, the creatinine and eGFR levels showed a trend for improvement until postoperative day 28 in tolvaptan-treated patients versus controls.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.